Authors
Latest:
Dr. Iagaru on Advancements in PSMA-PET Imaging for Prostate CancerAndrei H. Iagaru, MD, discusses key points from his presentation on the use of novel vs conventional imaging to manage metastatic hormone-sensitive prostate cancer.
Latest:
Dr. Balzarotti on the Challenges of Treating Elderly DLBCLMonica Balzarotti, MD, discusses the challenges of treating elderly patients with diffuse large B-cell lymphoma.
Latest:
Dr Wolf on Biomarkers Predicting Responses to Immunotherapy in Breast CancerDenise M. Wolf, PhD, discusses research into biomarkers predicting responses to immunotherapy in the phase 2 I-SPY2 trial in patients with early-stage breast cancer.
Latest:
Dr. Kundranda on the Sequencing of Second-Line Therapies in HCCMadappa Kundranda, MD, PhD, discusses the sequencing of second-line therapies in hepatocellular carcinoma.
Latest:
Dr. Michalski on the Goals ASTRO in Radiation OncologyJeff Michalski, MD, MBA, FASTRO, discusses the goals of the American Society for Radiation Oncology in radiation oncology.
Latest:
Immunotherapy Paves Path for New Standards of Care in Gastroesophageal CancersIt is crucial to understand and interpret the results from the landmark clinical trials in the context of recent FDA approvals in gastroesophageal cancers.
Latest:
Dr. Chatzkel on the Rationale for the IMMCO-1 trial in mCRPC and Other Immunologically Cold TumorsJonathan Chatzkel, MD, discusses the rationale for the phase Ib/II IMMCO-1 trial investigating the combination of atezolizumab plus tivozanib in metastatic castration-resistant prostate cancer and other immunologically cold tumors.
Latest:
Best Practices for Virtual Conference PresentationsAs the autumn and winter conference season approaches, Curtis Lachowiez, MD, reflects on the impact 2020 left on the field of oncology.
Latest:
Using Systemic Therapy to Treat HER2+ Breast CancerClosing thoughts from a discussion regarding the treatment landscape for HER2-positive breast cancer, with insight supporting the role of novel therapies to help personalize therapy.
Latest:
Dr Patel on the Evolving Use of Neoadjuvant PD-1 Inhibitors in CSCCVishal Patel, MD, FAAD, FACMS, discusses the evolving use of neoadjuvant and adjuvant PD-1 inhibition in cutaneous squamous cell carcinoma.
Latest:
Expanding Cancer Screening: The Future of Blood-Based TestingClosing out their panel, experts discuss the potential of blood-based tests to democratize access to cancer screening, complement existing protocols, and achieve early detection goals in the fight against cancer.
Latest:
Dr Appel on the Significance of International Childhood Cancer DayBurton Eliot Appel, MD, discusses the significance of International Childhood Cancer Day.
Latest:
Clinical Pearls and Closing Thoughts on NSCLC Treatment LandscapeClosing out their discussion on biomarker testing and targeted therapies in non–small cell lung cancer, the panel of expert oncologists share clinical pearls and thoughts on the evolving treatment landscape.
Latest:
Palliative Care for Young Adults Is a Growing Reality in CRCAlthough most younger patients received diagnoses of cancer of the rectum or distal colon, incidence rates are increasing across all colorectal anatomic subsites.
Latest:
Future Outlooks in the Treatment of R/R DLBCLShared insight on the future of diffuse large B-cell lymphoma management, highlighting unmet needs and hope for continued growth in the treatment landscape.
Latest:
Case Studies with Hepatic Artery InfusionRyan Merkow, MD, MS, and Louise Catherine Connell, MB BCh BAO, BMedSc, review cases of patients with colorectal cancer and provide insights on clinical practice.
Latest:
Dr Lee on Head and Neck Cancer Updates from the 2024 ACRO SummitAnna Lee, MD, MPH, discusses key takeaways from a presentation on managing head and neck cancers that was given at the 2024 ACRO Summit.
Latest:
Addressing Treatment Gaps in HER2+ MBCUnmet needs regarding the selection and sequencing of therapies for patients with HER2-positive metastatic breast cancer.
Latest:
Dr Epstein-Peterson on the Use of CAR T-Cell Therapy in MCLZachary Epstein-Peterson, MD, discusses the use of CAR T-cell therapy in mantle cell lymphoma and highlights questions that remain to be answered within the treatment landscape.
Latest:
Dr D’Amico on Advancements in High-Risk Prostate Cancer Diagnosis and ManagementAnthony V. D'Amico, MD, PhD, on the advancements in high-risk prostate cancer diagnosis and management
Latest:
Dr Johnson the Accuracy of Genomic Testing in Black Women With ER+ Breast CancerNathalie McDowell Johnson, MD, FACS, discusses the accuracy of genomic testing in Black women with estrogen receptor-positive breast cancer.
Latest:
Demystifying the Role of Palliative Care in the Oncology ClinicDespite American Society of Clinical Oncology guidelines calling for introduction of palliative care early in the course of disease, these services remain underused.
Latest:
Taking Organoids From Bench to Bedside Through Endoscopy in Pancreatic Cancer: Ongoing ResearchIn this seventh episode of OncChats: Taking Organoids From Bench to Bedside Through Endoscopy in Pancreatic Cancer, Toufic A. Kachaamy, MD, Madappa Kundranda, MD, PhD, and Richard Burkhart, MD, discuss ongoing research such as the PASS-01 trial (NCT04469556) in pancreatic cancer and ways to translate advances in the metastatic setting to the curative setting.
Latest:
Optimizing Care of Patients With Advanced Prostate Cancer: ConclusionSummarizes the main points and benefits of multidisciplinary prostate cancer care.
Latest:
Dr Garcia on the Future of the MELISA Trial in Ovarian CancerNúria Agustí Garcia, MD, discusses the mapping of sentinel lymph nodes in early-stage ovarian cancer.
Latest:
Dr. Kato on the Rationale For Investigating Dato-DXd Plus Durvalumab and Carboplatin in Advanced NSCLCTerufumi Kato, MD, Terufumi Kato, MD, Chief Physician, Department of Thoracic Oncology, Kanagawa Cancer Center, Yokohama, Japan, discusses the ongoing investigation of datopotamab deruxtecan in combination with durvalumab and carboplatin as a first-line treatment for patients with advanced metastatic non–small cell lung cancer.
Latest:
Dr Pagliaro on the Use of First-Line Avelumab Maintenance Therapy in Urothelial CarcinomaLance C. Pagliaro, MD, discusses the efficacy of first-line avelumab maintenance therapy, as seen in the phase 3 JAVELIN Bladder 100 trial in patients with advanced urothelial carcinoma.
Latest:
Dr. Pederson on the Importance of Ancestrally-Unbiased Polygenic Risk Assessment in Breast CancerHolly Pederson, MD, discusses the importance of ancestrally-unbiased polygenic risk assessment in patients with breast cancer.
